ticagrelor


Also found in: Medical, Wikipedia.
Related to ticagrelor: Prasugrel
Translations

ticagrelor

n ticagrelor m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
In an in vitro experiment,[2] ticagrelor was shown to increase the concentration of extracellular adenosine by inhibiting its uptake by red blood cells.
Effect of Ticagrelor on Coronary Blood Flow and Prognosis in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in Real World
Anglo-Swedish pharmaceutical firm AstraZeneca (LON: AZN) has issued a voluntary US recall for one lot of professional (physician) sample bottles of BRILINTA (ticagrelor) that contain eight 90mg tablets.
AstraZeneca voluntarily recalls sample bottles of Brilinta in the US
In a Medwatch alert in July 2015, the FDA noted that prescribing and dispensing errors had occurred because of the similarity in names of Brintellix and the blood thinner Brilinta (ticagrelor).
FDA approves changing brand name of Brintellix to Trintellix
15 September 2010 - Anglo-Swedish pharma major AstraZeneca (LON: AZN) (STO: AZN) said today the US Food and Drug Administration (FDA) postponed its decision on experimental blood thinner Brilinta (ticagrelor) by three months to 16 December 2010.
-AstraZeneca says US FDA extends Brilinta review by 3 months
-- The Food and Drug Administration's Cardiovascular and Renal Drugs Advisory Committee voted 7-1 to recommend approval of the platelet inhibitor ticagrelor to treat non-ST elevation myocardial infarction and ST-elevation myocardial infarction in patients intended to receive primary coronary intervention or who would be managed medically.
FDA panel backs approval of ticagrelor for ACS
PhaseBio Pharmaceuticals announced that results from the Phase 1 clinical trial of PB2452, a novel reversal agent for the antiplatelet drug ticagrelor, demonstrated that PB2452 provided immediate and sustained reversal of ticagrelor antiplatelet effects without report of drug-related serious adverse events.
PhaseBio announces results from Phase 1 clinical trial of PB2452
Background: There was still conflict on the antithrombotic advantage of ticagrelor versus clopidogrel among East Asian population with acute coronary syndrome (ACS).
Impact of Baseline Bleeding Risk on Efficacy and Safety of Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
CHICAGO--The benefit from dual-antiplatelet therapy in high-risk patients following a myocardial infarction was especially apparent in post-MI patients with diabetes in a prespecified secondary analysis from a multicenter trial of ticagrelor with more than 21,000 patients.
Ticagrelor cuts post-MI events in diabetes patients
AstraZeneca, a British-Swedish multinational pharmaceutical and biologics company, has received marketing authorisation from the European Commission for its Brilique (ticagrelor), it was reported yesterday.
AstraZeneca receives EC marketing authorisation for Brilique heart treatment
27 July 2010 - The Office of Clinical Pharmacology (OCP) under the US Food and Drug Administration (FDA) has recommended approval of experimental blood thinner Brilinta (ticagrelor) by Anglo-Swedish pharma major AstraZeneca plc (LON: AZN) (STO: AZN) but the market is divided on the news.
Market divided as FDA issues briefing information on AstraZeneca blood thinner
ORLANDO -- The investigational reversible oral antiplatelet drug ticagrelor proved superior to clopidogrel in all-cause mortality and other key end points in a major randomized trial involving 8,430 patients with ST-elevation MI.
New antiplatelet Rx bests clopidogrel in STEMI
Dictionary browser ?
Full browser ?